Outcomes associated with early rheumatoid arthritis

References

• St Clair EW, van der Heijde DM, Smolen JS et al. Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum.50, 3432–3443 (2004).
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum.52, 3381–3390 (2005).
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Weisman MH, Kavanaugh AF et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum.54, 26–37 (2006).
   PubMed Web of Science ®Google Scholar
• Mottonen T, Hannonen P, Leirisalo-Repo M et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet353, 1568–1573 (1999).
   PubMed Web of Science ®Google Scholar
• Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet364, 263–269 (2004).
   PubMed Web of Science ®Google Scholar
• Emery P. Treatment of rheumatoid arthritis. Br. Med. J.332, 152–155 (2006).
   PubMed Web of Science ®Google Scholar
• Dixon WG, Symmons DP. Does early rheumatoid arthritis exist? Best Pract. Res. Clin. Rheumatol.19, 37–53 (2005).
   PubMedGoogle Scholar
• Albers JM, Paimela L, Kurki P et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann. Rheum. Dis.60, 453–458 (2001).
   PubMed Web of Science ®Google Scholar
• Welsing PM, van Gestel AM, Swinkels HL et al. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum.44, 2009–2017 (2001).
   PubMed Web of Science ®Google Scholar
• Machold KP, Nell VP, Stamm TA et al. The Austrian early arthritis registry. Clin. Exp. Rheumatol.21(Suppl.31), S113–S117 (2003).
   Google Scholar
• Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum.24, 1308–1315 (1981).
   PubMed Web of Science ®Google Scholar
• Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J. Rheumatol.22, 639–643 (1995).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J. Rheumatol.23, 1407–1417 (1996).
   PubMed Web of Science ®Google Scholar
• Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford)45, 885–889 (2006).
   PubMed Web of Science ®Google Scholar
• Suurmeijer TP, Waltz M, Moum T et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum.45, 111–121 (2001).
   PubMed Web of Science ®Google Scholar
• Gerber LH, Furst G, Yarboro C, el-Gabalawy H. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis. Clin. Exp. Rheumatol.21(5 Suppl. 31), S65–S70 (2003).
   Google Scholar
• Treharne GJ, Kitas GD, Lyons AC, Booth DA. Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J. Health Psychol.10, 457–474 (2005).
   PubMed Web of Science ®Google Scholar
• Mottonen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy. Arthritis Rheum.39, 996–1005 (1996).
   PubMedGoogle Scholar
• Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br. J. Rheumatol.35, 1101–1105 (1996).
   PubMedGoogle Scholar
• Sokka T, Hannonen P. Utility of disease modifying antirheumatic drugs in “sawtooth” strategy. A prospective study of early rheumatoid arthritis patients up to 15 years. Ann. Rheum. Dis.58, 618–622 (1999).
   PubMedGoogle Scholar
• Harrison B, Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford)39, 939–949 (2000).
   PubMed Web of Science ®Google Scholar
• Young A, Dixey J, Cox N et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford)39, 603–611 (2000).
   PubMed Web of Science ®Google Scholar
• Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann. Rheum. Dis.61, 1055–1059 (2002).
   PubMed Web of Science ®Google Scholar
• Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum.46, 357–365 (2002).
   PubMed Web of Science ®Google Scholar
• Schumacher HR Jr , Habre W, Meador R, Hsia EC. Predictive factors in early arthritis: long-term followup. Semin. Arthritis Rheum.33, 264–272 (2004).
   PubMed Web of Science ®Google Scholar
• Tengstrand B, Ahlmen M, Hafstrom I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J. Rheumatol.31, 214–222 (2004).
   PubMed Web of Science ®Google Scholar
• Verstappen SM, van Albada-Kuipers GA, Bijlsma JW et al. Utrecht Rheumatoid Arthritis Cohort Study Group (SRU). A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Ann. Rheum. Dis.64, 38–43 (2005).
   PubMed Web of Science ®Google Scholar
• Makinen H, Kautiainen H, Hannonen P, Sokka T. Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study. J. Rheumatol.32, 796–800 (2005).
   PubMed Web of Science ®Google Scholar
• Stockman A, Tait BD, Wolfe R et al. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study. Rheumatol. Int.26(6), 500–509 (2005).
   PubMedGoogle Scholar
• Bruynesteyn K, van der Heijde D, Boers M et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum.46, 913–920 (2002).
   PubMed Web of Science ®Google Scholar
• Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann. Rheum. Dis.36, 71–73 (1977).
   PubMed Web of Science ®Google Scholar
• Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5–6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br. J. Rheumatol.35, 1106–1115 (1996).
   PubMedGoogle Scholar
• Drossaers-Bakker KW, Amesz E, Zwinderman AH, Breedveld FC, Hazes JM. A comparison of three radiologic scoring systems for the long-term assessment of rheumatoid arthritis: findings of an ongoing prospective inception cohort study of 132 women followed up for a median of twelve years. Arthritis Rheum.43, 1465–1472 (2000).
   PubMedGoogle Scholar
• Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D et al. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann. Rheum. Dis.60, 924–927 (2001).
   PubMed Web of Science ®Google Scholar
• Machold KP, Stamm TA, Eberl GJ et al. Very recent onset arthritis – clinical, laboratory, and radiological findings during the first year of disease. J. Rheumatol.29, 2278–2287 (2002).
   PubMedGoogle Scholar
• Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary care-based inception cohort of patients. Rheumatology (Oxford)41, 246–252 (2002).
   PubMedGoogle Scholar
• Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann. Rheum. Dis.62, 611–616 (2003).
   PubMed Web of Science ®Google Scholar
• Paulus HE, Oh M, Sharp JT et al. Western Consortium of Praticing Rheumatologists. Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis. J. Rheumatol.30, 705–713 (2003).
   PubMedGoogle Scholar
• Sanmarti R, Gomez A, Ercilla G et al. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting. Rheumatology (Oxford)42, 1044–1049 (2003).
   PubMed Web of Science ®Google Scholar
• Guillemin F, Gerard N, van Leeuwen M, Smedstad LM, Kvien TK, van den Heuvel W: EURIDISS Group. Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J. Rheumatol.30, 2585–2589 (2003).
   PubMed Web of Science ®Google Scholar
• Dixey J, Solymossy C, Young A. Early RA study. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS). J. Rheumatol.69, 48–54 (2004).
   Google Scholar
• Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis – results of an 8 year prospective study. J. Rheumatol.25, 417–426 (1998).
   PubMed Web of Science ®Google Scholar
• Egsmose C, Lund B, Borg G et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year follow up of a prospective double blind placebo controlled study. J. Rheumatol.22, 2208–2213 (1995).
   PubMed Web of Science ®Google Scholar
• Mottonen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy. Arthritis Rheum.39, 996–1005 (1996).
   PubMedGoogle Scholar
• Kaarela K, Kautiainen H. Continuous progression of radiological destruction in seropositive RA. J. Rheumatol.24, 1280–1284 (1997).
   PubMedGoogle Scholar
• Wick MC, Lindblad S, Weiss RJ, Klareskog L, van Vollenhoven RF. Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study. Scand. J. Rheumatol.33, 380–384 (2004).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis. Arthritis Rheum.41, 1571–1582 (1998).
   PubMedGoogle Scholar
• Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum.42, 1854–1860 (1999).
   PubMed Web of Science ®Google Scholar
• Welsing PM, Van Gestel AM, Swinkels HL, Kiemeney LA, Van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum.44, 2009–2017 (2001).
   PubMed Web of Science ®Google Scholar
• Odegard S, Landewe R, van der Heijde D, Kvien TK, Mowinckel P, Uhlig T. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum.54, 68–75 (2006).
   PubMed Web of Science ®Google Scholar
• Pollard L, Choy EH, Scott DL. The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin. Exp. Rheumatol.23(5 Suppl. 39), S43–S52 (2005).
   Web of Science ®Google Scholar
• Scott DL, Pugner K, Kaarela K et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford)39, 122–132 (2000).
   PubMed Web of Science ®Google Scholar
• Wiles N, Dunn G, Barrett E, Silman A, Symmons D. Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. J. Clin Epidemiol.53, 988–996 (2000).
   PubMedGoogle Scholar
• Kobelt G, Jonsson L, Lindgren P, Young A, Eberhardt K. Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. Arthritis Rheum.46, 2310–2319 (2002).
   PubMed Web of Science ®Google Scholar
• Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum.52, 2616–2624 (2005).
   PubMed Web of Science ®Google Scholar
• Salaffi F, Stancati A, Neri R, Grassi W, Bombardieri S. Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index. Clin. Exp. Rheumatol.23(5 Suppl. 39), S31–S42 (2005).
   Google Scholar
• West E, Jonsson SW. Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36. Clin. Rheumatol.24, 117–122 (2005).
   PubMed Web of Science ®Google Scholar
• Soderlin MK, Kautiainen H, Skogh T, Leirisalo-Repo M. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden. J. Rheumatol.31, 1717–1722 (2004).
   PubMed Web of Science ®Google Scholar
• Sharpe L, Sensky T, Brewin CR, Allard S. Characteristics of handicap for patients with recent onset rheumatoid arthritis: the validity of the Disease Repercussion Profile. Rheumatology (Oxford)40, 1169–1174 (2001).
   PubMedGoogle Scholar
• Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann. Rheum. Dis.61, 335–340 (2002).
   PubMed Web of Science ®Google Scholar
• Treharne GJ, Lyons AC, Booth DA, Mason SR, Kitas GD. Reactions to disability in patients with early versus established rheumatoid arthritis. Scand. J. Rheumatol.33, 30–38 (2004).
   PubMed Web of Science ®Google Scholar
• Treharne GJ, Kitas GD, Lyons AC, Booth DA. Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J. Health Psychol.10, 457–474 (2005).
   PubMed Web of Science ®Google Scholar
• Witney AG, Treharne GJ, Tavakoli M et al. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis. Rheumatology (Oxford)45, 975–981 (2006).
   PubMed Web of Science ®Google Scholar
• Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum.46, 2010–2019 (2002).
   PubMed Web of Science ®Google Scholar
• Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis.64, 1595–1601 (2005).
   PubMed Web of Science ®Google Scholar
• Kroot EJA, van Leeuwen MA, van Rijswijk MH et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann. Rheum. Dis.59, 954–958 (2000).
   PubMed Web of Science ®Google Scholar
• Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann. Rheum. Dis.58, 11–14 (1999).
   PubMed Web of Science ®Google Scholar
• Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation110, 1774–1779 (2004).
   PubMed Web of Science ®Google Scholar
• Pugner KM, Scott DL, Holmes JW, Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin. Arthritis Rheum.29, 305–320 (2000).
   PubMed Web of Science ®Google Scholar
• Hallert E, Husberg M, Skogh T. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project). Rheumatology (Oxford)45, 325–331 (2006).
   PubMed Web of Science ®Google Scholar
• Kobelt G, Lindgren P, Lindroth Y, Jacobson L, Eberhardt K. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford)44, 1169–1175 (2005).
   PubMed Web of Science ®Google Scholar
• Westhovens R, Boonen A, Verbruggen L et al. Healthcare consumption and direct costs of rheumatoid arthritis in Belgium. Clin. Rheumatol.24, 615–619 (2005).
   PubMed Web of Science ®Google Scholar
• Puolakka K, Kautiainen H, Mottonen T et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum.50, 55–62 (2004).
   PubMed Web of Science ®Google Scholar
• Nordmark B, Blomqvist P, Andersson B et al. A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support. Scand. J. Rheumatol.35, 7–14 (2006).
   PubMed Web of Science ®Google Scholar
• Gilworth G, Chamberlain MA, Harvey A et al. Development of a work instability scale for rheumatoid arthritis. Arthritis Rheum.49, 349–354 (2003).
   PubMed Web of Science ®Google Scholar
• Yelin E. Is early intervention worth it? J. Rheumatol. Suppl. 72, 36–38 (2005).
   Google Scholar
• Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P. Framework for design and evaluation of complex interventions to improve health. Br. Med. J. 321, 694–696 (2000).
   PubMed Web of Science ®Google Scholar
• Thornicroft G, Rose D. Health service research: is there anything to learn from mental health? J. Health Ser. Res. Policy10, 1–2 (2005).
   PubMedGoogle Scholar
• Thornicroft G, Tansella M. Growing recognition of the importance of service user involvement in mental health service planning and evaluation. Epidemiol. Psichiatr. Soc.14, 1–3 (2005).
   PubMed Web of Science ®Google Scholar
• Camberlin J. User/consumer involvement in mental health service delivery. Epidpeiol. Psichatr. Soc.14, 10–14 (2005).
   PubMedGoogle Scholar
• Lapsley P, Groves T. The patients journey: travelling through life with chronic illness. Br. Med. J.329, 598–584 (2004).
   Google Scholar
• Green J, Britten N. Qualitative research and evidence based medicine. Br. Med. J.316, 1230ndash;1232 (1998).
   PubMed Web of Science ®Google Scholar
• Lempp H, Scott D, Kingsley GH. The personal impact of rheumatoid arthritis on patients’ identity: a qualitative study. Chronic Illness2, 109–120 (2006).
   PubMedGoogle Scholar
• Lempp H, Scott D, Kingsley G. Patients’ views on the quality of health care for rheumatoid arthritis. Rheumatology (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• Simpson C, Franks C, Morrison C, Lempp H. The patient’s journey: rheumatoid arthritis. Br. Med. J.331, 887–889 (2005).
   PubMed Web of Science ®Google Scholar
• Bykerk VP, Keystone EC. What are the goals and principles of management in the early treatment of rheumatoid arthritis? Best Pract. Res. Clin. Rheumatol.19, 147–161 (2005).
   PubMed Web of Science ®Google Scholar
• Kingsley GH, Khoshaba B, Smith CM, Choy EH, Scott DL. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria. Rheumatology (Oxford)44, 629–632 (2005).
   PubMed Web of Science ®Google Scholar
• Sokka T, Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor-α agents in rheumatoid arthritis. Arthritis Rheum.48, 313–318 (2003).
   PubMed Web of Science ®Google Scholar
• Wiles NJ, Lunt M, Barrett EM et al. Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum.44, 1033–1042 (2001).
   PubMed Web of Science ®Google Scholar
• Vers tappen SM, Jacobs JW, Bijlsma JW et al. Utrecht Arthritis Cohort Study Group. Five-year follow up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum.48, 1797–1807 (2003).
   PubMedGoogle Scholar